Status:

COMPLETED

Colloids in Severe Trauma

Lead Sponsor:

University of the Philippines

Collaborating Sponsors:

Fresenius Kabi

Conditions:

Abdominal Hypertension

Abdominal Compartment Syndrome

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

Background: Fluid resuscitation is a cornerstone of the initial management of the critically injured trauma patient yet there are numerous controversies surrounding this very common practice. As a re...

Eligibility Criteria

Inclusion

  • Age: 18-65 years
  • Body weight: more than 40 kg
  • Trauma patients with onset of trauma ≤ 48h prior to assessment for inclusion in study, clinically judged to be in hemorrhagic shock by the attending surgeon and with 2 or more of the following characteristics:
  • Penetrating or blunt etiology with hemodynamic instability at ER or intra-operatively
  • Severely injured with Injury Severity Score (ISS) \> 15
  • Hypotension defined as either ≥ 10mmHg change in SBP or MAP ≤ 65 mmHg or needing vasopressors (dopamine ≥ 5 mcg/kg/min or norepinephrine at any dose) at the time of admission/referral
  • Hypoperfusion defined as base deficit ≥ 4 mmol/L

Exclusion

  • Known severe congestive heart failure (EF ≤ 35%)
  • Known chronic renal, liver or pancreatic disease
  • Known severe respiratory diseases e.g., TB, COPD, asthma
  • Known coagulopathy or bleeding tendency
  • Known allergy to Hydroxyethyl starch
  • Participation in a clinical drug trial within the last 2 months
  • Known Pregnancy or lactation
  • Severe traumatic brain injury GCS \< 9
  • Advanced cancer (stage IV or metastatic disease)
  • Patients receiving immunosuppressive drugs
  • Do-not-resuscitate status
  • Advanced directives restricting implementation of the protocol
  • Skeletal deformity, scarring, infection, gross contamination or previous surgery at the CVP insertion site
  • Severe hypoxemia if the CVP is to be inserted in the subclavian area
  • Known active gastrointestinal hemorrhage
  • Concomitant drug poisoning

Key Trial Info

Start Date :

May 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2009

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00890383

Start Date

May 1 2009

End Date

November 1 2009

Last Update

November 25 2009

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Jose Reyes Memorial Medical Center

Manila, National Capital Region, Philippines

2

East Avenue Medical Center

Quezon City, NCR, Philippines